These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1006 related items for PubMed ID: 9616974

  • 1. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 3. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 4. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep 04; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract] [Full Text] [Related]

  • 5. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 6. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002 Nov 24; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 7. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 24; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 8. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC, Burgess MA, Forrest JM.
    Commun Dis Intell; 1998 Aug 06; 22(8):157-8. PubMed ID: 9735550
    [No Abstract] [Full Text] [Related]

  • 9. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993 Aug 06; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 10. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986 Aug 06; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]

  • 11. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 06; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 12. The measles-mumps-rubella vaccination program in Finland.
    Redd SC, Wharton M, Hadler SC, Orenstein WA.
    N Engl J Med; 1995 Apr 20; 332(16):1102-3. PubMed ID: 7898540
    [No Abstract] [Full Text] [Related]

  • 13. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Apr 20; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 14. Need for measles revaccination.
    John TJ.
    Indian Pediatr; 1998 Aug 20; 35(8):789-91. PubMed ID: 10216577
    [No Abstract] [Full Text] [Related]

  • 15. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 16. [Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects].
    Bjerregaard P, Pedersen KM, Kamper-Jørgensen F, Koch C, Pedersen FK, Wagner AL, Zoffmann H.
    Ugeskr Laeger; 1985 Sep 16; 147(38):3013-7. PubMed ID: 4071749
    [No Abstract] [Full Text] [Related]

  • 17. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
    Rafuse J.
    CMAJ; 1996 May 15; 154(10):1567-8. PubMed ID: 8625011
    [Abstract] [Full Text] [Related]

  • 18. Mumps vaccination.
    Hilleman MR.
    Mod Trends Med Virol; 1970 May 15; 2(0):241-61. PubMed ID: 5527958
    [No Abstract] [Full Text] [Related]

  • 19. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 15; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 20. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA, Nasibov MN, Jakovleva NV.
    Bull World Health Organ; 1970 Mar 15; 42(2):283-9. PubMed ID: 5310140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.